Showing results (221-230 of 233) with videos related to
Sort By:
Pageof 24
European Journal of Immunology|April 13, 2000
Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNAJ Herkel, N Erez-Alon, A Mimran, et al.Acta Physiologica Scandinavica|November 1, 1992
Renal interstitial pressure and tubuloglomerular feedback control in rats during infusion of atrial natriuretic peptide (ANP)P Morsing, A Stenberg, D Casellas, et al.Nucleic Acids Research|January 29, 2002
Activation of p53 protein by telomeric (TTAGGG)n repeatsM Milyavsky, A Mimran, S Senderovich, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter studyT Hannedouche, J P Fillastre, A Mimran, et al.Journal of Autoimmunity|August 8, 2001
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodiesJ Herkel, A Mimran, N Erez, et al.American Journal of Hypertension|August 11, 2001
Endothelin gene variants and aortic and cardiac structure in never-treated hypertensivesM Lajemi, S Gautier, O Poirier, et al.Journal of Cardiovascular Pharmacology|January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)F R Bühler, G Berglund, O K Anderson, et al.Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Renin angiotensin aldosterone system, urinary prostaglandins and kallikrein in pregnancy induced hypertension. Evidence for a disregulation of the renin-angiotensin-prostacyclin loopP Fievet, A Fournier, E Agnes, et al.Journal of Human Hypertension|December 15, 2010
Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)A Januszewicz, E Ritz, G Viberti, et al.Diabetologia|October 31, 2009
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyE Ritz, G C Viberti, L M Ruilope, et al.Pageof 24